Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.
作者信息
Leroux Stéphanie, van den Anker Johannes N, Smits Anne, Pfister Marc, Allegaert Karel
机构信息
Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Neonatal Intensive Care Unit, University Hospital Rennes, Rennes, France.
出版信息
Br J Clin Pharmacol. 2019 May;85(5):865-867. doi: 10.1111/bcp.13899. Epub 2019 Mar 4.
Abstract
摘要
相似文献
1
Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.
Br J Clin Pharmacol. 2019 May;85(5):865-867. doi: 10.1111/bcp.13899. Epub 2019 Mar 4.
2
[Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):372-3. doi: 10.1016/j.eimc.2008.12.002. Epub 2009 Mar 31.
3
Making the change to area under the curve-based vancomycin dosing.
Am J Health Syst Pharm. 2018 Dec 15;75(24):1986-1995. doi: 10.2146/ajhp180034. Epub 2018 Oct 17.
4
Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
Int J Antimicrob Agents. 2021 Mar;57(3):106300. doi: 10.1016/j.ijantimicag.2021.106300. Epub 2021 Feb 7.
5
Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Bacteremia.
Ann Pharmacother. 2020 Jul;54(7):644-651. doi: 10.1177/1060028019897100. Epub 2019 Dec 30.
6
Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):338-341. doi: 10.1093/jpids/pix068.
7
Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Int J Antimicrob Agents. 2012 Nov;40(5):474-5. doi: 10.1016/j.ijantimicag.2012.06.020. Epub 2012 Aug 9.
8
Optimization of vancomycin dosing in very low-birth-weight preterm neonates.
Am J Perinatol. 2015 Jan;32(1):83-6. doi: 10.1055/s-0034-1376183. Epub 2014 May 16.
9
Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
Anaesthesiol Intensive Ther. 2019;51(3):218-223. doi: 10.5114/ait.2019.87362.
10
Outcomes associated with AUC24/MIC nomogram dosing of vancomycin.
Ann Pharmacother. 2011 May;45(5):687-9. doi: 10.1345/aph.1P495. Epub 2011 Apr 26.
引用本文的文献
1
Factors affecting free vancomycin concentration and target attainment of free area under the concentration-time curve.
J Pharm Health Care Sci. 2025 Feb 18;11(1):13. doi: 10.1186/s40780-025-00419-4.
2
Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates.
J Clin Pharmacol. 2025 Jul;65(7):923-932. doi: 10.1002/jcph.70003. Epub 2025 Feb 11.
3
Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
Antibiotics (Basel). 2023 Oct 26;12(11):1566. doi: 10.3390/antibiotics12111566.
4
Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants.
Biomedicines. 2023 Mar 17;11(3):940. doi: 10.3390/biomedicines11030940.
5
Use of Antibiotics in Preterm Newborns.
Antibiotics (Basel). 2022 Aug 23;11(9):1142. doi: 10.3390/antibiotics11091142.
6
Population Pharmacokinetics of Vancomycin in Pregnant Women.
Front Pharmacol. 2022 Jun 6;13:873439. doi: 10.3389/fphar.2022.873439. eCollection 2022.
7
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units.
Int J Clin Pharm. 2022 Apr;44(2):564-569. doi: 10.1007/s11096-021-01345-9. Epub 2021 Nov 2.
8
Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients.
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0120621. doi: 10.1128/AAC.01206-21. Epub 2021 Aug 16.
9
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper.
Br J Clin Pharmacol. 2022 Dec;88(12):4965-4984. doi: 10.1111/bcp.14958. Epub 2021 Jul 23.
10
Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine.
Front Pediatr. 2021 Apr 1;9:590969. doi: 10.3389/fped.2021.590969. eCollection 2021.
本文引用的文献
1
Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.
J Antimicrob Chemother. 2019 Aug 1;74(8):2128-2138. doi: 10.1093/jac/dkz158.
2
Factors impacting unbound vancomycin concentrations in neonates and young infants.
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1503-1510. doi: 10.1007/s10096-018-3277-8. Epub 2018 May 16.
3
Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
BMC Pediatr. 2016 Dec 8;16(1):206. doi: 10.1186/s12887-016-0753-0.
4
Unanswered Questions Regarding Optimal Pediatric Vancomycin Use.
Ther Drug Monit. 2016 Jun;38(3):419-20. doi: 10.1097/FTD.0000000000000289.
5
Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.
Br J Clin Pharmacol. 2013 Jul;76(1):58-64. doi: 10.1111/bcp.12053.
6
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.
Br J Clin Pharmacol. 2013 Apr;75(4):1068-80. doi: 10.1111/j.1365-2125.2012.04406.x.
7
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration.
Semin Fetal Neonatal Med. 2013 Feb;18(1):28-34. doi: 10.1016/j.siny.2012.10.003. Epub 2012 Nov 6.
8
Renal drug clearance in preterm neonates: relation to prenatal growth.
Ther Drug Monit. 2007 Jun;29(3):284-91. doi: 10.1097/FTD.0b013e31806db3f5.
9
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
Clin Pharmacokinet. 2004;43(13):925-42. doi: 10.2165/00003088-200443130-00005.
Zotero 插件